https://doi.org/10.1186/s10020-019-0099-9
F
Feng Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
24
Papers
982
Citations
13
h-index
13
i10-index
Feng Li is an academic researcher from Shanxi Provincial Cancer Hospital. The author has contributed to research in topics: Immune cells in cancer & MicroRNA in disease regulation & Advanced biosensing and bioanalysis techniques. The author has an h-index of 13, co-authored 21 publications.
Papers by this author
worksFBXW7 suppresses HMGB1-mediated innate immune signaling to attenuate hepatic inflammation and insulin resistance in a mouse model of nonalcoholic fatty liver disease
2019 · Molecular Medicine · 22 citations
Myotubularin related protein 7 is essential for the spermatogonial stem cell homeostasis via PI3K/AKT signaling
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.9761681
Quasispecies of SARS-CoV-2 revealed by single nucleotide polymorphisms (SNPs) analysis
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.14672298
Peroxisomal lipid metabolism inhibits Pimozide-induced cancer cell death by regulating ATP homeostasis
2025 · Oncogenesis · 0 citations
https://doi.org/10.1038/s41389-025-00575-0
MiR-106b-5p promotes gastric cancer progression by directly targeting the tumor suppressor RBL2
2025 · Scientific Reports · 0 citations
https://doi.org/10.1038/s41598-025-30601-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat